Zion Market Research has published a new report titled “Oligonucleotide Synthesis Market by Offering (Equipment, Reagents and Consumables, and Synthesized Oligonucleotides [Product and Services), by Application (Research, Therapeutics, and Diagnostics), and by End-User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2026”. According to the report, the global oligonucleotide synthesis market was valued at approximately USD 1,508 million in 2017 and is expected to generate around USD 3,697 million by 2026, at a CAGR of around 10.6% between 2019 and 2026.
Small fragments of nucleic acids that are synthesized via enzyme chemistry and genetic engineering are known as oligonucleotides. These are mainly used in laboratories for diagnostics, therapeutics, and in academic and industrial research. Oligonucleotides are also used for initial screening of target validation and drug production. The oligonucleotides synthesis market is likely to benefit from the constant growth of gene editing and genomics markets, as there are a large number of advancements related to genetic tools for simplifying the synthesis of oligonucleotide process.
The global market for oligonucleotide synthesis is segmented on the basis of offering, application, and end-user. By offering, the oligonucleotide synthesis market is segmented into equipment, reagents and consumables, and synthesized oligonucleotides. The synthesized oligonucleotides market is further divided into product and services. The products segment includes large-scale synthesis oligonucleotides, probes, primers, linkers and adaptors, intermediate-scale synthesis oligonucleotides, and others. The services segment includes custom/specialty oligonucleotides (modified and non-modified oligonucleotides) and pre-designed oligonucleotides. The growing applications of ready-to-use synthesized oligonucleotides in therapeutics and a large number of manufacturers offering various customizations is likely to drive the synthesized oligonucleotides segment in the years ahead. By application, this global market includes research, therapeutics, and diagnostics. The research segment includes polymerase chain reaction, qPCR, next-generation sequencing, and others. The therapeutics segment includes antisense oligonucleotides, RNAi, nucleic acid aptamers, and immunotherapy applications. There is a rising demand for oligonucleotides for diagnostic purposes due to its growing demand for molecular diagnosis of inherited disorders. By end-user, the market includes pharmaceutical and biotechnology companies, diagnostic laboratories, academic research institutes, and others. Pharmaceutical and biotechnology companies are more focused on finding alternative approaches to disease treatment, thereby, making significant use of oligonucleotides. This, in turn, is offering an effective mode of action for treatment of various indications at a comparatively low development cost.
By region, the global oligonucleotide synthesis market includes North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America is anticipated to dominate the market for oligonucleotide synthesis and hold a major share of the oligonucleotide synthesis market over the forecast timeline. This regional dominance can be attributed to the growing prevalence of genetic diseases and the subsequent demand for new and advanced drugs. The Asia Pacific and European regions are likely to register a rise in their market valuation over the estimated timeframe. The Asia Pacific oligonucleotide synthesis market is projected to be driven by the strong presence of innumerable companies offering consumables and reagents for oligonucleotide synthesis and the increased need for better health outcomes, the rising prevalence of infectious and chronic diseases, and the availability of improved healthcare infrastructure in the region.
Some leading players of the global oligonucleotide synthesis market include ATD Bio Ltd., BianoScience GmbH, BioSpring GmbH, Bioneer Corporation, Bio-Synthesis, Inc., Creative Biogene, Dalton Pharma Services, Eurofins Genomics, GE, GeneDesign, Inc., GenScript, IBA GmbH, Integrated DNA Technologies, Inc., Kaneka Eurogentec S.A., LGC Biosearch Technologies, Merck KGaA, Microsynth AG, Syngene, Thermo Fisher Scientific, Inc., TriLink BioTechnologies, LLC, and Twist Bioscience.
This report segments the global oligonucleotide synthesis market into:
Global Oligonucleotide Synthesis Market: Offering Analysis
Global Oligonucleotide Synthesis Market: Application Analysis
Global Oligonucleotide Synthesis Market: End-User Analysis
Global Oligonucleotide Synthesis Market: Regional Analysis
You can Buy This Report from Here @ https://www.zionmarketresearch.com/buynow/su/oligonucleotide-synthesis-market/news